605 related articles for article (PubMed ID: 24168081)
1. Clinical significance of macrophage heterogeneity in human malignant tumors.
Komohara Y; Jinushi M; Takeya M
Cancer Sci; 2014 Jan; 105(1):1-8. PubMed ID: 24168081
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophages: from basic research to clinical application.
Yang L; Zhang Y
J Hematol Oncol; 2017 Feb; 10(1):58. PubMed ID: 28241846
[TBL] [Abstract][Full Text] [Related]
3. Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.
Wu K; Lin K; Li X; Yuan X; Xu P; Ni P; Xu D
Front Immunol; 2020; 11():1731. PubMed ID: 32849616
[TBL] [Abstract][Full Text] [Related]
4. Human breast cancer cells educate macrophages toward the M2 activation status.
Sousa S; Brion R; Lintunen M; Kronqvist P; Sandholm J; Mönkkönen J; Kellokumpu-Lehtinen PL; Lauttia S; Tynninen O; Joensuu H; Heymann D; Määttä JA
Breast Cancer Res; 2015 Aug; 17(1):101. PubMed ID: 26243145
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages, potential targets for cancer treatment.
Yang L; Zhang Y
Biomark Res; 2017; 5():25. PubMed ID: 28804638
[TBL] [Abstract][Full Text] [Related]
6. Role of tumor-associated macrophages in human malignancies: friend or foe?
Takeya M; Komohara Y
Pathol Int; 2016 Sep; 66(9):491-505. PubMed ID: 27444136
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival.
Cieslewicz M; Tang J; Yu JL; Cao H; Zavaljevski M; Motoyama K; Lieber A; Raines EW; Pun SH
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):15919-24. PubMed ID: 24046373
[TBL] [Abstract][Full Text] [Related]
8. Convergent pathways of macrophage polarization: The role of B cells.
Sica A; Porta C; Riboldi E; Locati M
Eur J Immunol; 2010 Aug; 40(8):2131-3. PubMed ID: 20623553
[TBL] [Abstract][Full Text] [Related]
9. M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma.
Falleni M; Savi F; Tosi D; Agape E; Cerri A; Moneghini L; Bulfamante GP
Melanoma Res; 2017 Jun; 27(3):200-210. PubMed ID: 28272106
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration.
Zhang Y; Sime W; Juhas M; Sjölander A
Eur J Cancer; 2013 Oct; 49(15):3320-34. PubMed ID: 23810249
[TBL] [Abstract][Full Text] [Related]
11. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
12. The cell-cell interaction between tumor-associated macrophages and small cell lung cancer cells is involved in tumor progression via STAT3 activation.
Iriki T; Ohnishi K; Fujiwara Y; Horlad H; Saito Y; Pan C; Ikeda K; Mori T; Suzuki M; Ichiyasu H; Kohrogi H; Takeya M; Komohara Y
Lung Cancer; 2017 Apr; 106():22-32. PubMed ID: 28285690
[TBL] [Abstract][Full Text] [Related]
13. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide.
Genin M; Clement F; Fattaccioli A; Raes M; Michiels C
BMC Cancer; 2015 Aug; 15():577. PubMed ID: 26253167
[TBL] [Abstract][Full Text] [Related]
14. Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages.
Kwon Y; Kim M; Kim Y; Jung HS; Jeoung D
Front Immunol; 2020; 11():1167. PubMed ID: 32595638
[TBL] [Abstract][Full Text] [Related]
15. Macrophages associated with tumors as potential targets and therapeutic intermediates.
Vinogradov S; Warren G; Wei X
Nanomedicine (Lond); 2014 Apr; 9(5):695-707. PubMed ID: 24827844
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumour strategies aiming to target tumour-associated macrophages.
Tang X; Mo C; Wang Y; Wei D; Xiao H
Immunology; 2013 Feb; 138(2):93-104. PubMed ID: 23113570
[TBL] [Abstract][Full Text] [Related]
17. Diverse macrophages polarization in tumor microenvironment.
Rhee I
Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
[TBL] [Abstract][Full Text] [Related]
18. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
20. Macrophage polarization in health and disease.
Cassetta L; Cassol E; Poli G
ScientificWorldJournal; 2011; 11():2391-402. PubMed ID: 22194670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
